Distinct mechanisms for activation of the opioid receptor-like 1 and κ- opioid receptors by nociceptin and dynorphin A

Molecular Pharmacology

Volumn 55, Issue 2, 1999, Pages 324-331

  Mollereau, Catherine ^a   Mouledous, Lionel ^a   Lapalu, Sophie ^a   Cambois, Gilles ^a   Moisand, Christiane ^a   Butour, Jean Luc ^a   Meunier, Jean Claude ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPRENORPHINE; DYNORPHIN A; KAPPA OPIATE RECEPTOR; NOCICEPTIN; OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; CHIMERA; CHINESE HAMSTER; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0033023897     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.2.324     Document Type: Article

References (39)

1. Alla SA, Quitterer U, Grigoriev S, Maidhof A, Haasemann M, Jarnagin K and Muller-Esterl W (1996) Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies. J Biol Chem 271:1748-1755.
2. Alvarez R and Daniels DV (1992) A separation method for the assay of adenylylcyclase, intracellular cyclic AMP, and cyclic AMP phosphodiesterase using tritium-labeled substrates. Anal Biochem 203:76-82.
3. Befort K, Tabbara L, Kling D, Maigret B and Kieffer B (1996) Role of aromatic transmembrane residues of the δ-opioid receptor in ligand recognition. J Biol Chem 271:10161-10168.
4. Butour J-L, Moisand C, Mazarguil H, Mollereau C and Meunier J-C (1997) Recognition and activation of the opioid receptor-like ORL1 receptor by nociceptin, nociceptin analogs and opioids. Eur J Pharmacol 321:97-103.
5. Champion HC and Kadowitz PJ (1997) Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat. Life Sci 60:PL241-245.
6. Chavkin C and Goldstein A (1981) Specific receptor for the opioid peptide dynorphin: Structure-activity relationships. Proc Natl Acad Sci USA 78:6543-6547.
7. Chen C and Okayama H (1987) High efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
8. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
9. Devine DP, Reinscheid RK, Monsma FJ Jr, Civelli O and Akil H (1996b) The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res 727:225-229.
10. Devine DP, Taylor L, Reinscheid RK, Monsma FJ Jr, Civelli O and Akil H (1996a) Rats rapidly develop tolerance to the locomotor-inhibiting effects of the novel neuropeptide orphanin FQ. Neurochem Res 21:1387-1396.
11. Dooley CT and Houghten RA (1996) Orphanin FQ: Receptor binding and analog structure activity relationships in rat brain. Life Sci 59:PL23-29.
12. Dooley CT, Spaeth CG, Bertzetei-Gureke IP, Craymer K, Adapa ID, Brandt SR, Houghten RA and Toll L (1997) Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1. J Pharmacol Exp Ther 283:735-741.
13. Elies R, Fu LXM, Eftekhari P, Wallukat G, Schulze W, Granier C, Hjalmarson A and Hoebeke J (1998) Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor. Eur J Biochem 251:659-666.
14. Guerrini R, Calo' G, Rizzi A, Bianchi C, Lazarus LH, Salvadori S, Temussi PA and Regoli D (1997) Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem 40:1789-1793.
15. Kapusta DR, Sezen SF, Chang J-K, Lippton H and Kenigs VA (1997) Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ). Life Sci 60:PL15-21.
16. Lapalu S, Moisand C, Butour J-L, Mollereau C and Meunier J-C (1998) Different domains of the ORL1 and κ-opioid receptors are involved in recognition of nociceptin and dynorphin A. FEBS Lett 427:296-300.
17. Lapalu S, Moisand C, Mazarguil H, Cambois G, Mollereau C and Meunier J-C (1997) Comparison of the structure-activity relationships of nociceptin and dynorphin A using chimeric peptides. FEBS Lett 417:333-336.
18. Mansour A, Hoversten MT, Taylor LP, Watson SJ and Akil H (1995) The cloned μ, δ and κ receptors and their endogenous ligands: Evidence for two opioid peptide recognition cores. Brain Res 700:89-98.
19. Meng F, Taylor LP, Hoversten MT, Ueda Y, Ardati A, Reinscheid RK, Monsma FJ Jr, Watson SJ, Civelli O and Akil H (1996) Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. J Biol Chem 271:32016-32020.
20. Metzger TG and Ferguson DM (1995) On the role of extracellular loops of opioid receptors in conferring ligand specificity. FEBS Lett 375:1-4.
21. Meunier J-C, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour J-L, Guillemot J-C, Ferrara P, Monsarrat B, Mazarguil H, Vassart G, Parmentier M and Costentin J (1995) Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor Nature 377:532-535
22. Mogil JS, Grisel JE, Reinscheid RK, Civelli O, Belknap JK and Grandy DK (1996a) Orphanin FQ is a functional anti-opioid peptide. Neuroscience 75:333-337.
23. Mogil JS, Grisel JE, Zhangs G, Belknap JK and Grandy DK (1996b) Functional antagonism of mu-, delta- and kappa-opioid antinociception by orphanin FQ. Neurosci Lett 214:131-134.
24. Mollereau C, Moisand C, Butour J-L, Parmentier M and Meunier J-C (1996a) Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids. FEBS Lett 395:17-21.
25. Mollereau C, Parmentier M, Mailleux P, Butour J-L, Moisand C, Chalon P, Caput D, Vassart G and Meunier J-C (1994) ORL1, a novel member of the opioid receptor family: Cloning, functional expression and localization. FEBS Lett 341:33-38.
26. Mollereau C, Simons MJ, Soularue P, Liners F, Vassart G, Meunier J-Cl and Parmentier M (1996b) Structure, tissue distribution, and chromosomal localization of the prepronociceptin gene. Proc Natl Acad Sci USA 93:8666-8670.
27. Nothacker HP, Reinscheid RK, Mansour A, Henningsen RA, Ardati A, Monsma FJ Jr, Watson SJ and Civelli O (1996) Primary structure and tissue distribution of the orphanin FQ precursor. Proc Natl Acad Sci USA 93:8677-8682.
28. Paterlini G, Portoghese PS and Ferguson DM (1997) Molecular simulation of dynorphin A-(1-10) binding to extracellular loop 2 of the κ-opioid receptor. J Med Chem 40:3254-3262.
29. Pomonis JD, Billington CJ and Levine AS (1996) Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats. Neuroreport 8:369-371.
30. Pogozheva, ID, Lomize, AL and Mosberg, HI (1998) Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. Biophys J 75:612-634.
31. Reinscheid RK, Ardati A, Monsma FJ Jr and Civelli O (1996) Structure-activity relationship studies on the novel neuropeptide orphanin FQ. J Biol Chem 271: 14163-14168.
32. Reinscheid RK, Higelin J, Henningsen RA, Monsma FJ Jr and Civelli O (1998) Structures that delineate orphanin FQ and dynorphin A pharmacological selectivities. J Biol Chem 273:1490-1495.
33. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ and Civelli O (1995) Orphanin FQ: A neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270:792-794.
34. Samson M, LaRosa G, Libert F, Paindavoine P, Detheux M, Vassart G and Parmentier M (1997) The second extracellular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem 272:24934-24941.
35. Sandin J, Georgieva J, Schött PA, Ogren SO and Terenius L (1997) Nociceptin/ orphanin FQ microinjected into hippocampus impairs spatial learning in rats. Eur J Neurosci 9:194-197.
36. Topham CM, Moulédous L, Poda G, Maigret B and Meunier J-C (1998) Molecular modelling of the ORL1 receptor and its complex with nociceptin. Protein Eng 11: 1163-1179.
37. Wang JB, Johnson PS, Wu JM, Wang WF and Uhl GR (1994) Human κ opiate receptor second extracellular loop elevates dynorphin's affinity for human μ/κ chimeras. J Biol Chem 269:25966-25969.
38. Xu X-J, Hao J-X and Wiesenfeld-Hallin Z (1996) Nociceptin or antinociceptin: Potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport 7:2092-2094.
39. Xue J-C, Chen C, Zhu J, Kunapuli S, DeRiel JK, Yu L and Liu-Chen L-Y (1994) Differential binding domains of peptide and non-peptide ligands in the cloned κ opioid receptor. J Biol Chem 269:30195-30199.